Pharmacokinetics and pharmacodynamics of insulin aspart, a rapid-acting analog of human insulin, in healthy Japanese volunteers
- 1 August 2000
- journal article
- research article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 49 (2-3) , 119-126
- https://doi.org/10.1016/s0168-8227(00)00151-0
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Comparison of the time-action profiles of U40- and U100-regular human insulin and the rapid-acting insulin analogue B28 AspExperimental and Clinical Endocrinology & Diabetes, 1997
- Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study GroupDiabetes, 1997
- Insulinkinetic and -Dynamic in Diabetic Patients Under Insulin Pump Therapy After Injections of Human Insulin or the Insulin Analogue (B28Asp)Hormone and Metabolic Research, 1995
- Action Profile of the Rapid Acting Insulin Analogue: Human Insulin B28AspDiabetic Medicine, 1993
- Relationship Between Absorption of Radiolabeled Soluble Insulin, Subcutaneous Blood Flow, and AnthropometryDiabetes Care, 1992
- Absorption Kinetics and Action Profiles of Subcutaneously Administered Insulin Analogues (AspB9GluB27, AspB10, AspB28) in Healthy SubjectsDiabetes Care, 1991
- Comparison of Subcutaneous Soluble Human Insulin and Insulin Analogues (AspB9, GluB27; AspB10; AspB28) on Meal-Related Plasma Glucose Excursions in Type I Diabetic SubjectsDiabetes Care, 1991
- Monomeric Insulins and Their Experimental and Clinical ImplicationsDiabetes Care, 1990
- “Normal” Insulin Secretion: The Goal of Artificial Insulin Delivery Systems?Diabetes Care, 1980
- RATE OF CLEARANCE OF INSULIN LABELLED WITH 131I FROM THE SUBCUTANEOUS TISSUES: IN NORMAL AND DIABETIC SUBJECTSThe Lancet, 1959